The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
In situ assessment of the role of the β1, β2‐ and β3‐adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue
Open accessAbstract
The involvment of β 1, β 2‐ and β 3‐adrenoceptors in the control of lipolysis and nutritive blood flow was investigated in abdominal subcutaneous adipose tissue of healthy young adults by use of an in situ microdialysis technique. Dialysis probes were infused either with isoprenaline (non‐selective β‐adrenoceptor agonist), CGP 12,177 (selective β 3‐adrenoceptor agonist having β 1‐/β 2‐antagonist properties), dobutamine (selective β 1‐adrenoceptor agonist) or terbutaline (selective β 2‐adrenoceptor agonist). The recovery of each probe used for perfusion was calculated by an in vivo calibration method. The local blood flow was estimated through the measurement of the escape of ethanol infused simultaneously with the drugs included in the probe. Isoprenaline infusion at 0.01 μ m had a weak effect while higher concentrations of isoprenaline (0.1 and 1 μ m) caused a rapid, sustained and concentration‐dependent increase of glycerol outflow; the maximum increase was 306±34% with 1 μ m. Isoprenaline also increased the nutritive blood flow in adipose tissue; a significant effect appeared at 0.1 μ m isoprenaline and was greater at 1 μ m. CGP 12,177 (10 and 100 μ m) increased the glycerol concentration in the dialysate (128±8 and 149±12%, respectively) and nutritive blood flow. Terbutaline and dobutamine (100 μ m) both provoked rapid and similar increases in glycerol outflow (252±18 and 249±18%, respectively). Both, terbutaline and dobutamine increased nutritive blood flow. It is concluded that β 1 and β 2‐adrenoceptor subtypes are both mainly involved in the mobilization of lipids and in the control of nutritive blood flow. β 3‐Adrenoceptors play a weaker role in the control of lipolysis and nutritive blood flow in human subcutaneous abdominal adipose tissue.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue distribution of beta 3-adrenergic receptor mRNA in man
Krief, S., Lönnqvist, F., Raimbault, S., Baude, B., Van Spronsen, A., Arner, P., Strosberg, A. D., Ricquier, D., & Emorine, L. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116191 · Cited by 528
Mechanisms for differences in lipolysis between human subcutaneous and omental fat cells
Hellmer, J. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.1.15 · Cited by 66
Cited by
Lipolysis and lipid mobilization in human adipose tissue
Lafontan, M., & Langin, D. (2009) · Progress in Lipid Research · doi:10.1016/j.plipres.2009.05.001 · Cited by 826
Self-citationIntegrative physiology of human adipose tissue
Frayn, K. N., Karpe, F., Fielding, B. A., Macdonald, I. A., & Coppack, S. W. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802326 · Cited by 467
Large, V, Hellström, L., Reynisdottir, S., Lönnqvist, F., Eriksson, P., Lannfelt, L., & Arner, P. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119854 · Cited by 420
Dissecting adipose tissue lipolysis: molecular regulation and implications for metabolic disease
Nielsen, T. S., Jessen, N., Jørgensen, J. O. L., Møller, N., & Lund, S. (2014) · Journal of Molecular Endocrinology · doi:10.1530/jme-13-0277 · Cited by 380
Langin, D. (2006) · Pharmacological Research · doi:10.1016/j.phrs.2006.03.009 · Cited by 359
Metadata
- Authors
- Barbe, P., Millet, L., Galitzky, J., Lafontan, M., & Berlan, M.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 1996-03
- Volume
- 117
- Issue
- 5
- Pages
- 907-913
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2091158130
- Cited by
- 175
- References
- 2
- FWCI
- 6.46
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: In situ assessment of the role of the β1, β2‐ and β3‐adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue. https://app.cochat.ai/papers/10.1111/j.1476-5381.1996.tb15279.x
- The paper
- Barbe, P., Millet, L., Galitzky, J., Lafontan, M., & Berlan, M. (1996). In situ assessment of the role of the β1, β2‐ and β3‐adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue. British Journal of Pharmacology. https://doi.org/10.1111/j.1476-5381.1996.tb15279.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.